Stock Analysis
Inspire Medical Systems, Inc. (INSP) Stock Analysis
Inspire Medical Systems, Inc. (INSP) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Inspire Medical Systems, Inc. (INSP) currently has an AIQ Score of 65/100, indicating a neutral setup. Quality is the strongest factor at 77/100. Value is the weakest current factor at 49/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
INSP at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $63.08 |
| AIQ Score | 65/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $1.78B |
| P/E Ratio | 13.2 |
| Forward P/E | — |
| EPS | $0.01 |
| Revenue TTM | $200.58M |
| Dividend Yield | 0.00% |
| Beta | 0.67 |
| Volume | 425.72K |
| 52-week range | $38.91-$147.03 |
| RSI 14 | 68.27 |
| 50-Day SMA | $55.01 |
| 200-Day SMA | $66.19 |
| Analyst Price Target | $57.10 |
| Next Earnings | Nov 2, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
INSP
OverviewINSP Stock Analysis Summary
Inspire Medical Systems, Inc. (INSP) currently has an AIQ Score of 65/100, indicating a neutral setup. Quality is the strongest factor at 77/100. Value is the weakest current factor at 49/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, INSP has AIQ Score of 65/100 with Quality base of 77/100 and fading Value at 49/100. Wait for component alignment before adding exposure.
Quality (77/100) leads while Value (49/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 1.51% stock move · INSP classified in Medical - Devices.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is INSP Bullish or Bearish Right Now?
INSP currently has a neutral overall setup. Quality is the strongest factor at 77/100, while Value is weakest at 49/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 77/100.
- - Momentum is constructive at 70/100.
- - Risk Resilience is supportive at 62/100.
- - Price is +14.67% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (35 vs 6).
- - Price is -4.69% below its 200-day SMA.
- - Analyst target implies -9.48% downside from the latest quote.
Current Consensus
INSP's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 4 neutral, and 6 sell votes. INSP's 14-day RSI is 68.27, which places the stock in a constructive momentum range. INSP's beta is 0.67, indicating lower market sensitivity than the broad market.
What Changed in INSP?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the INSP Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
INSP Decision Framework
Public evidence layers, setup checks, and risk context for Inspire Medical Systems, Inc..
Inspire Medical Systems, Inc. (INSP) Stock Analysis
Inspire Medical Systems, Inc. has an AIQ Score of 65/100 in a Neutral regime. Quality is strongest at 77/100. Beta is 0.67, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | INSP is in a Neutral AIQ regime with score 65/100. |
| Signal Conflict | The primary conflict is that quality leads at 77/100 while value lags at 49/100. |
| Factor Evidence | Momentum 70/100 · Value 49/100 · Quality 77/100 · Risk 62/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 77/100.
Momentum is 70/100 and RSI (14) is 68.3.
INSP is in a Neutral regime at 65/100.
Risk factor is 62/100 with beta 0.67 and annual volatility 70.59%.
Current conflict: quality leads at 77/100 while value lags at 49/100.
INSP Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
INSP Fundamentals
INSP valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
INSP Technical Analysis
INSP technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
INSP Stock Catalysts
Track INSP earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
INSP Dividend Analysis
INSP dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
INSP Financial Data
INSP revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
INSP Risk Analysis
INSP volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
INSP Stock News
INSP stock news, market tone, recent headlines, and catalyst context.
INSP vs Medical Devices Peers
Current peer cohort: INSP · ISRG · LMAT · MDT · MTD. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| INSP Current stock | 65/100 | 49/100 | 70/100 | 62/100 | -0.16 | 70.59% | Current |
| ISRG Intuitive Surgical | 47/100 | 26/100 | 24/100 | 66/100 | -0.51 | 36.59% | INSP vs ISRG |
| LMAT LeMaitre Vascular | 50/100 | 32/100 | 38/100 | 63/100 | -0.27 | 44.83% | INSP vs LMAT |
| MDT Medtronic | 68/100 | 58/100 | 70/100 | 73/100 | 0.01 | 23.44% | INSP vs MDT |
| MTD Mettler-Toledo | 29/100 | 30/100 | 15/100 | 56/100 | 0.18 | 31.86% | INSP vs MTD |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 5, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 6, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching INSP
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for INSP
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
INSP Stock FAQ
What is INSP stock price today?
Inspire Medical Systems, Inc.'s current stock price is $63.08. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is INSP bullish or bearish right now?
INSP's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is INSP's market cap?
INSP's market cap is $1.78B based on the latest completed market-close snapshot from Sep 4, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is INSP's current P/E ratio?
INSP's current P/E ratio is 13.2 based on the latest completed market-close snapshot from Sep 4, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is INSP's RSI?
INSP's 14-day RSI is 68.27 based on the latest completed market-close snapshot from Sep 4, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is INSP above its 50-day and 200-day moving averages?
INSP is 14.67% from its 50-day SMA and -4.69% from its 200-day SMA based on the latest completed market-close snapshot from Sep 4, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is INSP's next earnings date?
INSP's next earnings date is currently listed as Nov 2, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does INSP pay a dividend?
INSP's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 4, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.